Stifel Initiates Altimmune(ALT.US) With Buy Rating, Announces Target Price $18

Moomoo News18:31 ET · Ratings

Innovative Breakthrough in Metabolic Disease Treatment: Annabel Samimy's Buy Rating on Altimmune's Pemvidutide

TipRanks16:25 ET

Altimmune Initiated With a Buy at Stifel

TipRanks16:15 ET · Ratings

FDA Issues Draft Guidance on Developing Weight Loss Drugs

Seeking Alpha11:53 ET

Institutional Owners May Consider Drastic Measures as Altimmune, Inc.'s (NASDAQ:ALT) Recent US$56m Drop Adds to Long-term Losses

Simply Wall StJan 2 05:56 ET

Jim Cramer on Altimmune, Inc. (ALT): 'Healthcare Is So Out Of Fashion'

Yahoo FinanceDec 28, 2024 15:39 ET